Immunophenotypic Characterization of Benign and Malignant Prostatic Lesions-Reference-Cited by-同舟云学术

Immunophenotypic Characterization of Benign and Malignant Prostatic Lesions

Published:2007-07 Issue:3 Volume:63 Page:243-248
ISSN:0377-1237
Container-title:Medical Journal Armed Forces India
language:en
Short-container-title:Medical Journal Armed Forces India

Author:

Lakhtakia R,Bharadwaj R,Kumar VK,Mandal P,Nema SK

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Cancer Statistics CA;Boring;Cancer J Clin,1994

2. National Cancer Registry Programme. Consolidated Report Population Based Cancer Registries (PBCRs 1990–1996). Indian Council of Medical Research, New Delhi, Aug 2001.

3. The case for no initial treatment of localized prostate cancer;Smith;Urol Clin North Am,1990

4. Case control study of screening for prostate cancer by digital rectal examinations;Friedman;Lancet,1991

5. Prostate-specific antigen testing in the new millennium;Fong;BJU Int,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and Prognostic Role of Prostate-Specific Antigen Immunologic Staining in Prostate Cancer;Shiraz E-Medical Journal;2023-04-11

2. An Unusual Case of Myelodysplastic Syndrome With Intrahepatic Extramedullary Hematopoiesis Leading to Liver Failure;Cureus;2022-03-01

3. Aberrant Expression of p63 in an Adenocarcinoma of the Prostate That Has Metastasized to the Oral Cavity;Cureus;2022-03-01

4. High mortality risk of prostate cancer patients in Asia and West Africa: A systematic review;Avicenna Journal of Medicine;2020

5. Diagnostic utility of triple antibody (AMACR, HMWCK and P63) stain in prostate neoplasm;Journal of Family Medicine and Primary Care;2019